Skip to main content
. 2023 Jan 24;13:964915. doi: 10.3389/fphar.2022.964915

TABLE 4.

Secondary outcomes of intensive regimen vs. standard regimen.

Outcome N1 (E/S) N2 (E/S) OR 95% CI I2 (%)
Nausea 115/902 135/767 .75 .57–1.00 19
Vomiting 32/709 45/578 .60 .38–.97 11
Bloating 96/902 101/767 .72 .40–1.30 61
Abdominal pain 70/902 50/767 1.21 .83–1.79 32
Tolerability 786/874 600/723 1.19 .56–2.54 68

N1, number of intensive regimens; N2, number of standard regimens; E/S, event/sample size; OR, odds ratio; CI, confidence interval; I2 >50% indicates high heterogeneity.